Sweden-based Sigrid Raises USD5M Funding

Support from both existing and new international investors highlights confidence in Sigrid’s clinically validated platform and accelerating U.S. commercial growth.

The funds will be used to expand operations and accelerate R&D efforts.

Led by CEO Sana Alajmovic, Sigrid develops non-systemic, clinically validated technologies that work mechanically in the gut without entering the body. Its patented SiPore technology enables solutions for everyday glucose and weight management, and is applied across oral health, veterinary care, and food technology.

Read Also - ShanX Medtech Secures €24 M To Bring Ultra-Rapid Antimicrobial Susceptibility Diagnostics To Market

As metabolic health becomes a global priority, consumers, patients and clinicians are increasingly seeking practical, science-backed solutions that deliver measurable effects on blood sugar and weight.

Sigrid’s dietary supplement, Glucose Stabiliser, is rapidly gaining traction through direct-to-consumer channels and a growing U.S. physician network. Over the past 12 months, the product has achieved over 3× revenue growth, demonstrating strong product-market fit and repeat usage in a fast-growing category.

"We're seeing a fundamental shift in how people approach metabolic health " said Sana Alajmovic Co-Founder and CEO of Sigrid. "Blood sugar control and sustainable weight management have become top priorities, and expectations for clinically validated solutions are rising.

With one of the most well-validated non-systemic platform technologies in the category Sigrid is uniquely positioned to meet this demand. This investment allows us to accelerate our U.S. expansion while advancing new verticals powered by our SiPore® technology."

Following the successful submission of its technical file for CE-mark approval in the EU, Sigrid is advancing toward authorization of a first-of-its-kind over-the-counter medical device designed to support weight reduction and metabolic health in adults with excess weight and elevated blood sugar, as part of a structured lifestyle management program.

About Sigrid

Sigrid is a Swedish medtech and consumer health company advancing metabolic health through non systemic clinically validated technologies. Its patented SiPore® platform works mechanically in the gut without entering the body, enabling safe scalable solutions for glucose and weight management and driving innovation in oral health,veterinary care and food technology.